The March issue of the Journal of Drugs in Dermatology (JDD) gathers a timely, practice‑oriented collection of studies and reports selected as this month’s Editor’s Picks — spanning potential disease‑modifying implications of antiviral therapy, long‑term biologic data, evolving topical and systemic options for inflammatory skin disease, and a range of hair‑ and nail‑focused investigations that carry direct clinical relevance.
Explore this month’s top picks below:
Antiviral Treatment of Herpes Simplex Virus Decreases the Risk of Alzheimer’s Disease and Dementia aims to evaluate whether antiviral therapy for oral, mucocutaneous, or anogenital HSV lowers the subsequent risk of AD and dementia.
Brodalumab’s 8-Year Journey in Plaque Psoriasis: Insights Into Efficacy, Safety, and Real-World Evidence suggests that brodalumab is an important, well-tolerated therapeutic option for achieving high levels of disease control in patients with moderate-to-severe psoriasis.
Advanced Topical Nonsteroidal Therapies for Atopic Dermatitis: Consensus Statements From an Expert Panel proposes expert consensus statements to define the clinical role of advanced topical nonsteroidal therapies in AD.
Updates on Therapeutic Approaches for Management of Androgenetic Alopecia examines the current and emerging treatment landscape for AGA, focusing on various topical, oral, injectable, and non-pharmacological interventions.
Efficacy, Safety, and Real-World Aspects of Janus Kinase Inhibitors to Treat Patients With Alopecia Areata discuss the efficacy, safety, and real-world aspects of treatment for an advanced practice provider audience.
From Bald to Bold: Reversal of Alopecia Totalis in an Adolescent Using Dupilumab Monotherapy reports on case of a 13-year-old male patient with a past medical history of AD and food atopy, who presented with AA to the scalp.
A Decade of Hair Prosthetic Injuries: A Review of United States Emergency Department Cases (2013-2022) encourages dermatologists to increase patient education and preventative measures to minimize prosthetic injury.
Transitioning From Anti-aging to Skin Activation: Limiting Cellular Fatigue and Senescence for Skin Longevity introduces a dermatologic strategy for promoting skin longevity, supported by clinical and preclinical evidence.
Management of Nail Toxicities From Fibroblast Growth Factor Receptor Inhibitors conducted a systematic literature review, including case reports, trials, and retrospective studies reporting FGFRi-related nail disorders.
Persistent Alopecic Patches Following Dutasteride Mesotherapy for Female Androgenetic Alopecia: A Case Series highlights the variability of clinical and trichoscopic findings in post-mesotherapy alopecia, ranging from permanent scarring to non-scarring alopecia.
Find more JDD Issue Highlights here.